Hsieh TY - Search Results

1

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.

Lu MY, Huang CF, Hung CH, Tai CM, Mo LR, Kuo HT, Tseng KC, Lo CC, Bair MJ, Wang SJ, Huang JF, Yeh ML, Chen CT, Tsai MC, Huang CW, Lee PL, Yang TH, Huang YH, Chong LW, Chen CL, Yang CC, Yang SS, Cheng PN, Hsieh TY, Hu JT, Wu WC, Cheng CY, Chen GY, Zhou GX, Tsai WL, Kao CN, Lin CL, Wang CC, Lin TY, Lin CL, Su WW, Lee TH, Chang TS, Liu CJ, Dai CY, Kao JH, Lin HC, Chuang WL, Peng CY, Tsai CW, Chen CY, Yu ML; TACR Study Group. Lu MY, et al. Among authors: hsieh ty. Clin Mol Hepatol. 2024 Jan;30(1):64-79. doi: 10.3350/cmh.2023.0287. Epub 2023 Nov 21. Clin Mol Hepatol. 2024. PMID: 38195113 Free PMC article.

2

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

Liu CJ, Lai MY, Chao YC, Liao LY, Yang SS, Hsiao TJ, Hsieh TY, Lin CL, Hu JT, Chen CL, Chen PJ, Kao JH, Chen DS. Liu CJ, et al. Among authors: hsieh ty. Hepatology. 2006 Apr;43(4):742-9. doi: 10.1002/hep.21100. Hepatology. 2006. PMID: 16557544 Clinical Trial.

3

Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.

Hsu C, Yang TS, Huo TI, Hsieh RK, Yu CW, Hwang WS, Hsieh TY, Huang WT, Chao Y, Meng R, Cheng AL. Hsu C, et al. Among authors: hsieh ty, hsieh rk. J Hepatol. 2012 May;56(5):1097-1103. doi: 10.1016/j.jhep.2011.12.013. Epub 2012 Jan 13. J Hepatol. 2012. PMID: 22245891 Clinical Trial.

4

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir.

Wang CC, Tseng KC, Peng CY, Hsieh TY, Lin CL, Su TH, Tseng TC, Hsu CS, Lin HH, Kao JH. Wang CC, et al. Among authors: hsieh ty. J Gastroenterol Hepatol. 2013 Jan;28(1):46-50. doi: 10.1111/j.1440-1746.2012.07269.x. J Gastroenterol Hepatol. 2013. PMID: 22989322

5

Association between chronic hepatitis C virus infection and bone mineral density.

Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC. Lin JC, et al. Among authors: hsieh ty. Calcif Tissue Int. 2012 Dec;91(6):423-9. doi: 10.1007/s00223-012-9653-y. Epub 2012 Oct 5. Calcif Tissue Int. 2012. PMID: 23052227

6

Hepatitis C virus infection in patients with primary biliary cirrhosis.

Chen HW, Huang HH, Lai CH, Chang WE, Shih YL, Chang WK, Hsieh TY, Chu HC. Chen HW, et al. Among authors: hsieh ty. Ann Hepatol. 2013 Jan-Feb;12(1):78-84. Ann Hepatol. 2013. PMID: 23293197 Free article.

7

Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan.

Lin JA, Chen YC, Cheng SN, Chen PJ, Chu HC, Hsieh TY, Shih YL. Lin JA, et al. Among authors: hsieh ty. J Formos Med Assoc. 2014 Oct;113(10):727-33. doi: 10.1016/j.jfma.2013.10.010. Epub 2013 Nov 11. J Formos Med Assoc. 2014. PMID: 24231092 Free article.

8

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.

Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Peng CY, et al. Among authors: hsieh ty, hsieh tc. J Formos Med Assoc. 2015 Apr;114(4):308-13. doi: 10.1016/j.jfma.2013.10.023. Epub 2013 Dec 5. J Formos Med Assoc. 2015. PMID: 24315616 Free article.

9

Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.

Chien RN, Peng CY, Kao JH, Hu TH, Lin CC, Hu CT, Chen CY, Hsieh TY, Lin HC, Chuang WL; Taiwan NA-Registry Group. Chien RN, et al. Among authors: hsieh ty. J Gastroenterol Hepatol. 2014 Jan;29(1):185-92. doi: 10.1111/jgh.12416. J Gastroenterol Hepatol. 2014. PMID: 24354995

10

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.

Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Wang CC, et al. Among authors: hsieh ty. Hepatol Int. 2016 Mar;10(2):294-301. doi: 10.1007/s12072-015-9662-9. Epub 2015 Sep 23. Hepatol Int. 2016. PMID: 26399763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters